Valuation: C-Rad AB

Market Cap 121.56Cr 13Cr 11Cr 10Cr 9.44Cr 18Cr 1.22TCr 18Cr 48Cr 612.1Cr 48Cr 47Cr 2.03TCr P/E 2026 *
18.2x
P/E 2027 * 15.2x
Enterprise Value 104.48Cr 11Cr 9.49Cr 8.92Cr 8.11Cr 15Cr 1.05TCr 15Cr 41Cr 526.1Cr 41Cr 40Cr 1.75TCr EV / Sales 2026 *
2.25x
EV / Sales 2027 * 1.91x
Free-Float
50.36%
Yield 2026 *
1.25%
Yield 2027 * 1.81%
1 week-0.28%
Current month-3.26%
1 month-4.56%
3 months+2.01%
6 months+25.80%
Current year+12.84%
1 week 35.4
Extreme 35.4
36.8
1 month 35.3
Extreme 35.3
38.25
3 years 24.8
Extreme 24.8
49.3
5 years 24.8
Extreme 24.8
67
Manager TitleAgeSince
Chief Executive Officer 56 02/02/2026
Chief Executive Officer - 21/10/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 52 01/01/2017
Director/Board Member 60 07/05/2021
Chairman 61 05/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-0.28%+6.27%+16.34% 13Cr
-1.28%-0.96%+20.30%+11.24% 22TCr
-0.71%-1.13%-4.02%-19.91% 14TCr
-1.68%+4.14%-17.85%+31.80% 14TCr
+0.27%+5.11%-49.76%+0.72% 7.51TCr
-1.04%+2.10%+17.05%+16.26% 5.28TCr
-0.50%-0.31%-17.32%-15.27% 5.07TCr
-0.51%+1.75%+24.61%+22.39% 4.19TCr
-0.32%+1.31%+41.37%+49.96% 4.05TCr
-0.14%+2.68%+0.40%+4.27% 3.33TCr
Average -0.66%+1.61%+2.10%+11.78% 8.82TCr
Weighted average by Cap. -0.90%+1.12%+0.46%+9.18%

Financials

2026 *2027 *
Net sales 46Cr 4.88Cr 4.21Cr 3.96Cr 3.6Cr 6.77Cr 466.44Cr 6.88Cr 18Cr 233.58Cr 18Cr 18Cr 776.22Cr 53Cr 5.54Cr 4.79Cr 4.5Cr 4.09Cr 7.69Cr 529.93Cr 7.82Cr 21Cr 265.37Cr 21Cr 20Cr 881.87Cr
Net income 6.68Cr 70.29L 60.71L 57.05L 51.88L 97.54L 67Cr 99.15L 2.61Cr 34Cr 2.64Cr 2.58Cr 111.85Cr 7.96Cr 83.74L 72.32L 67.96L 61.81L 1.16Cr 80Cr 1.18Cr 3.11Cr 40Cr 3.14Cr 3.08Cr 133.25Cr
Net Debt -17Cr -1.8Cr -1.55Cr -1.46Cr -1.33Cr -2.49Cr -171.74Cr -2.53Cr -6.68Cr -86Cr -6.74Cr -6.6Cr -285.8Cr -21Cr -2.19Cr -1.89Cr -1.78Cr -1.62Cr -3.04Cr -209.8Cr -3.09Cr -8.16Cr -105.06Cr -8.24Cr -8.06Cr -349.12Cr
Logo C-Rad AB
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Employees
-
Date Price Change
17/26/17 SEK 35.50 -0.28%
14/26/14 SEK 35.60 -0.28%
13/26/13 SEK 35.70 -0.56%
12/26/12 SEK 35.90 +1.41%
11/26/11 SEK 35.40 -1.39%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
36.00SEK
Average target price
45.00SEK
Spread / Average Target
+25.00%

Quarterly revenue - Rate of surprise